Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
  1. 2019
  2. Published
  3. Published

    The majority of newly diagnosed myeloma patients do not fulfill the inclusion criteria in clinical phase III trials

    Klausen, T. W., Gregersen, H., Abildgaard, N., Andersen, N. F., Frølund, U. C., Gimsing, P., Helleberg, C. & Vangsted, A. J., 2019, In : Leukemia. 33, p. 546-549 5 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. 2018
  5. Published

    Risk factors for blood stream infections in multiple myeloma: A population-based study of 1154 patients in Denmark

    Sørrig, R., Klausen, T. W., Salomo, M., Vangsted, A. & Gimsing, P., Jul 2018, In : European Journal of Haematology. 101, 1, p. 21-27 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  6. Published

    Lenalidomide versus lenalidomide + dexamethasone prolonged treatment after second-line lenalidomide + dexamethasone induction in multiple myeloma

    Lund, J., Gruber, A., Lauri, B., Duru, A. D., Blimark, C., Swedin, A., Hansson, M., Forsberg, K., Ahlberg, L., Carlsson, C., Waage, A., Gimsing, P., Vangsted, A. J., Frølund, U., Holmberg, E., Gahrton, G., Alici, E., Hardling, M., Mellqvist, U-H. & Nahi, H., Jun 2018, In : Cancer Medicine. 7, 6, p. 2256-2268 13 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  7. Published
  8. Published

    Early relapsed disease of multiple myeloma following up-front HDM-ASCT: a study based on the Danish Multiple Myeloma Registry in the period 2005 to 2014

    Helm-Petersen, S., Sørrig, R., Klausen, T. W., Preiss, B., Frølund, U. C., Helleberg, C., Breinholt, M., Andersen, M. K., Abildgaard, N., Gimsing, P. & Vangsted, A. J., 22 Feb 2018, In : Leukemia. 32, 9, p. 2054-2057

    Research output: Contribution to journalJournal articleResearchpeer-review

  9. Published

    Drug response prediction in high-risk multiple myeloma

    Vangsted, A. J., Helm-Petersen, S., Cowland, J. B., Jensen, P. B., Gimsing, P., Barlogie, B. & Knudsen, S., 20 Feb 2018, In : Gene. 644, p. 80-86 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  10. 2017
  11. Published

    Causes of early death in multiple myeloma patients treated with high-dose therapy followed by autologous stem cell transplantation: A study based on the nationwide Danish Multiple Myeloma Registry

    Thidemann Andersen, K., Klausen, T., Abildgaard, N., Klarskov Andersen, M., Frost Andersen, N., Christian Frølund, U., Helleberg, C., Kjeldsen, E., Pedersen, P., Helm-Petersen, S., Svirskaite, A., Preiss, B., Gimsing, P. & Juul Vangsted, A., Oct 2017, In : American Journal of Hematology. 92, 10, p. E611-E614

    Research output: Contribution to journalJournal articleResearchpeer-review

  12. Published

    The impact of comorbidity on mortality in multiple myeloma: a Danish nationwide population-based study

    Gregersen, H., Vangsted, A. J., Abildgård, N., Andersen, N. F., Pedersen, R. S., Frølund, U. C., Helleberg, C., Broch, B., Pedersen, P. T., Gimsing, P. & Klausen, T. W., Jul 2017, In : CME Cancer Medicine. 6, 7, p. 1807-1816 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  13. Published

    Dual inhibition of DNMTs and EZH2 can overcome both intrinsic and acquired resistance of myeloma cells to IMiDs in a Cereblon-independent manner

    Dimopoulos, K., Søgaard Helbo, A., Fibiger Munch-Petersen, H., Sjö, L., Christensen, J., Sommer Kristensen, L., Asmar, F., Hermansen, E., O'Connel, C., Gimsing, P., Liang, G. & Grønbaek, K., 2017, In : Molecular Oncology. 12, 2, p. 180-195

    Research output: Contribution to journalJournal articleResearchpeer-review

  14. Published

    Immunoparesis in newly diagnosed Multiple Myeloma patients: Effects on overall survival and progression free survival in the Danish population

    Sørrig, R., Klausen, T. W., Salomo, M., Vangsted, A. J., Frølund, U. C., Andersen, K. T., Klostergaard, A., Helleberg, C., Pedersen, R. S., Pedersen, P. T., Helm-Petersen, S., Teodorescu, E. M., Preiss, B., Abildgaard, N., Gimsing, P. & Danish Myeloma Study Group, 2017, In : P L o S One. 12, 12, p. e0188988

    Research output: Contribution to journalJournal articleResearchpeer-review

  15. 2016
  16. Published

    Phase 1/2 study of daratumumab, lenalidomide, and dexamethasone for relapsed multiple myeloma

    Plesner, T., Arkenau, H-T., Gimsing, P., Krejcik, J., Lemech, C., Minnema, M. C., Lassen, U., Laubach, J. P., Palumbo, A., Lisby, S., Basse, L., Wang, J., Sasser, A. K., Guckert, M. E., de Boer, C., Khokhar, N. Z., Yeh, H., Clemens, P. L., Ahmadi, T., Lokhorst, H. M. & Richardson, P. G., 16 Aug 2016, In : Blood. 128, 14, p. 1821-1828

    Research output: Contribution to journalJournal articleResearchpeer-review

  17. Published
  18. Published

    The Danish National Multiple Myeloma Registry

    Gimsing, P., Holmström, M. O., Klausen, T. W., Andersen, N. F., Gregersen, H., Pedersen, R. S., Plesner, T., Pedersen, P. T., Frederiksen, M., Frølund, U., Helleberg, C., Vangsted, A., de Nully Brown, P. & Abildgaard, N., 2016, In : Clinical Epidemiology. 8, p. 583-587 5 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  19. 2015
  20. Published

    Smoldering multiple myeloma risk factors for progression: a Danish population-based cohort study

    Sørrig, R., Klausen, T. W., Salomo, M., Vangsted, A. J., Østergaard, B., Gregersen, H., Frølund, U. C., Andersen, N. F., Helleberg, C., Andersen, K. T., Pedersen, R. S., Pedersen, P., Abildgaard, N., Gimsing, P. & Danish Myeloma Study Group, 29 Dec 2015, In : European Journal of Haematology.

    Research output: Contribution to journalJournal articleResearchpeer-review

  21. Published

    American Society of Blood and Marrow Transplantation, European Society of Blood and Marrow Transplantation, Blood and Marrow Transplant Clinical Trials Network, and International Myeloma Working Group Consensus Conference on Salvage Hematopoietic Cell Transplantation in Patients with Relapsed Multiple Myeloma

    Giralt, S., Garderet, L., Durie, B., Cook, G., Gahrton, G., Bruno, B., Hari, P., Lokhorst, H., McCarthy, P., Krishnan, A., Sonneveld, P., Goldschmidt, H., Jagannath, S., Barlogie, B., Mateos, M., Gimsing, P., Sezer, O., Mikhael, J., Lu, J., Dimopoulos, M., Mazumder, A., Palumbo, A., Abonour, R., Anderson, K. M., Attal, M., Blade, J., Bird, J., Cavo, M., Comenzo, R., de la Rubia, J., Einsele, H., Garcia-Sanz, R., Hillengass, J., Holstein, S., Johnsen, H. E., Joshua, D., Koehne, G., Kumar, S., Kyle, R., Leleu, X., Lonial, S., Ludwig, H., Nahi, H., Nooka, A., Orlowski, R., Rajkumar, V., Reiman, A., Richardson, P., Riva, E., San Miguel, J., Turreson, I., Usmani, S., Vesole, D., Bensinger, W., Qazilbash, M., Efebera, Y., Mohty, M., Gasparreto, C., Gajewski, J., LeMaistre, C. F., Bredeson, C., Moreau, P., Pasquini, M., Kroeger, N. & Stadtmauer, E., Dec 2015, In : Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 21, 12, p. 2039-51 13 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  22. Published

    Growth differentiation factor 15 (GDF15) promotes osteoclast differentiation and inhibits osteoblast differentiation and high serum GDF15 levels are associated with multiple myeloma bone disease

    Westhrin, M., Moen, S. H., Holien, T., Mylin, A. K., Heickendorff, L., Olsen, O. E., Sundan, A., Turesson, I., Gimsing, P., Waage, A. & Standal, T., Dec 2015, In : Haematologica. 100, 12, p. e511-4

    Research output: Contribution to journalJournal articleResearchpeer-review

  23. Published

    Salvage bortezomib-dexamethasone and high-dose melphalan (HDM) and autologous stem cell support (ASCT) in myeloma patients at first relapse after HDM with ASCT. A phase-2 trial

    Gimsing, P., Hjertner, Ø., Abildgaard, N., Andersen, N. F., Dahl, T. G., Gregersen, H., Klausen, T. W., Mellqvist, U-H., Linder, O., Lindås, R., Clausen, N. T. & Lenhoff, S., Oct 2015, In : Bone Marrow Transplantation. 50, 10, p. 1306-11 6 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  24. Published

    Targeting CD38 with Daratumumab Monotherapy in Multiple Myeloma

    Lokhorst, H. M., Plesner, T., Laubach, J. P., Nahi, H., Gimsing, P., Hansson, M., Minnema, M. C., Lassen, U., Krejcik, J., Palumbo, A., van de Donk, N. W. C. J., Ahmadi, T., Khan, I., Uhlar, C. M., Wang, J., Sasser, A. K., Losic, N., Lisby, S., Basse, L., Brun, N. & Richardson, P. G., 24 Sep 2015, In : The New England journal of medicine. 373, 13, p. 1207-19 13 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  25. Published

    A Phase I Dose-Escalation Study of Antibody BI-505 in Relapsed/Refractory Multiple Myeloma

    Hansson, M., Gimsing, P., Badros, A., Niskanen, T. M., Nahi, H., Offner, F., Salomo, M., Sonesson, E., Mau-Sørensen, M., Stenberg, Y., Sundberg, A., Teige, I., Van Droogenbroeck, J., Wichert, S., Zangari, M., Frendeus, B., Korsgren, M., Poelman, M. & Tricot, G., 15 Jun 2015, In : Clinical Cancer Research. 21, 12, p. 2730-6 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  26. Published

    Serum YKL-40: a new independent prognostic marker for skeletal complications in patients with multiple myeloma

    Mylin, A. K., Abildgaard, N., Johansen, J. S., Heickendorff, L., Kreiner, S., Waage, A., Turesson, I., Gimsing, P. & for the Nordic Myeloma Study Group, 11 Feb 2015, In : Leukemia and Lymphoma. 56, 9, p. 2650-59 1 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  27. Published

    Causes of early death in multiple myeloma patients who are ineligible for high-dose therapy with hematopoietic stem cell support: A study based on the nationwide Danish Myeloma Database

    Holmström, M. O., Gimsing, P., Abildgaard, N., Andersen, N. F., Helleberg, C., Clausen, N. A. T., Klausen, T. W., Frederiksen, M., Kristensen, D. L., Larsen, H., Pedersen, P. T., Andersen, K. T., Pedersen, R. S., Jensen, B. A., Gregersen, H. & Vangsted, A. J., 5 Jan 2015, In : American Journal of Hematology. 90, 4, p. E73-74

    Research output: Contribution to journalJournal articleResearchpeer-review

  28. Published

    Does low-molecular-weight heparin influence the antimyeloma effects of thalidomide? A retrospective analysis of data from the GIMEMA, Nordic and Turkish myeloma study groups

    Beksac, M., Waage, A., Bringhen, S., Kristinsson, S. Y., Sucak, G. T., Gimsing, P., Lupparelli, G., Fıratlı-Tuğlular, T., Juliusson, G., Turesson, I. & Palumbo, A., 2015, In : Acta Haematologica. 133, 4, p. 372-80 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  29. Published

    N-terminal pro-C-type natriuretic peptide in serum associated with bone destruction in patients with multiple myeloma

    Mylin, A. K., Goetze, J. P., Heickendorff, L., Ahlberg, L., Dahl, I. M., Abildgaard, N., Gimsing, P. & Nordic Myeloma Study Group, 2015, In : Biomarkers in Medicine. 9, 7, p. 679-89 11 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  30. Published

    Polymorphisms in the heparanase gene in multiple myeloma association with bone morbidity and survival

    Andersen, N. F., Vogel, U., Klausen, T. W., Gimsing, P., Gregersen, H., Abildgaard, N. & Vangsted, A. J., 2015, In : European Journal of Haematology. 94, 1, p. 60-66

    Research output: Contribution to journalJournal articleResearchpeer-review

  31. 2014
  32. Published

    Characteristics and Long-Term Outcome of Patients with Systemic Immunoglobulin Light-Chain Amyloidosis

    Nelson, L. M., Gustafsson, F. & Gimsing, P., 16 Dec 2014, In : Acta Haematologica. 133, 4, p. 336-346 11 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  33. Published

    Panobinostat plus bortezomib and dexamethasone versus placebo plus bortezomib and dexamethasone in patients with relapsed or relapsed and refractory multiple myeloma: a multicentre, randomised, double-blind phase 3 trial

    San-Miguel, J. F., Hungria, V. T. M., Yoon, S-S., Beksac, M., Dimopoulos, M. A., Elghandour, A., Jedrzejczak, W. W., Günther, A., Nakorn, T. N., Siritanaratkul, N., Corradini, P., Chuncharunee, S., Lee, J-J., Schlossman, R. L., Shelekhova, T., Yong, K., Tan, D., Numbenjapon, T., Cavenagh, J. D., Hou, J., LeBlanc, R., Nahi, H., Qiu, L., Salwender, H., Pulini, S., Moreau, P., Warzocha, K., White, D., Bladé, J., Chen, W., de la Rubia, J., Gimsing, P., Lonial, S., Kaufman, J. L., Ocio, E. M., Veskovski, L., Sohn, S. K., Wang, M-C., Lee, J. H., Einsele, H., Sopala, M., Corrado, C., Bengoudifa, B-R., Binlich, F. & Richardson, P. G., Oct 2014, In : Lancet Oncology. 15, 11, p. 1195-206 12 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  34. Published

    Genetic variants in the P2RX7 gene are associated with risk of multiple myeloma

    Vangsted, A. J., Klausen, T. W., Gimsing, P., Abildgaard, N., Andersen, N. F., Gang, A. O., Holmström, M. O., Gregersen, H., Vogel, U., Schwarz, P. & Jørgensen, N. R., Aug 2014, In : European Journal of Haematology. 93, 2, p. 172-4 3 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  35. Published

    Bortezomib, melphalan, prednisone (VMP) versus melphalan, prednisone, thalidomide (MPT) in elderly newly diagnosed multiple myeloma patients: A retrospective case-matched study

    Morabito, F., Bringhen, S., Larocca, A., Wijermans, P., Victoria Mateos, M., Gimsing, P., Mazzone, C., Gottardi, D., Omedè, P., Zweegman, S., José Lahuerta, J., Zambello, R., Musto, P., Magarotto, V., Schaafsma, M., Oriol, A., Juliusson, G., Cerrato, C., Catalano, L., Gentile, M., Isabel Turel, A., Marina Liberati, A., Cavalli, M., Rossi, D., Passera, R., Rosso, S., Beksac, M., Cavo, M., Waage, A., San Miguel, J., Boccadoro, M., Sonneveld, P., Palumbo, A. & Offidani, M., Apr 2014, In : American Journal of Hematology. 89, 4, p. 355-62 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  36. Published

    The role of epigenetics in the biology of multiple myeloma

    Dimopoulos, K., Gimsing, P. & Grønbæk, K., 2014, In : Blood Cancer Journal. 4, p. e207

    Research output: Contribution to journalJournal articleResearchpeer-review

  37. 2013
  38. Published

    Primary localised cutaneous amyloidosis - a systematic review

    Kaltoft, B., Schmidt, G., Lauritzen, A. F. & Gimsing, P., Nov 2013, In : Danish Medical Bulletin (Online). 60, 11, p. A4727

    Research output: Contribution to journalJournal articleResearchpeer-review

  39. Published

    Aberrant microRNA expression in multiple myeloma

    Dimopoulos, K., Gimsing, P. & Grønbæk, K., Aug 2013, In : European Journal of Haematology. 91, 2, p. 95-105 11 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  40. Published

    CD138+ cell separation affects cancer gene expression in human myeloma cell lines

    Sørrig, R., Hermansen, N. E. U., Hother, C. & Gimsing, P., Aug 2013, In : European Journal of Haematology. 91, 2, p. 187-8 2 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  41. Published

    Bortezomib consolidation after autologous stem cell transplantation in multiple myeloma: a Nordic Myeloma Study Group randomized phase 3 trial

    Mellqvist, U-H., Gimsing, P., Hjertner, O., Lenhoff, S., Laane, E., Remes, K., Steingrimsdottir, H., Abildgaard, N., Ahlberg, L., Blimark, C., Dahl, I. M., Forsberg, K., Gedde-Dahl, T., Gregersen, H., Gruber, A., Guldbrandsen, N., Haukås, E., Carlson, K., Kvam, A. K., Nahi, H., Lindås, R., Andersen, N. F., Turesson, I., Waage, A., Westin, J. & Nordic Myeloma Study Group, 6 Jun 2013, In : Blood. 121, 23, p. 4647-54 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  42. Published

    Safety of thalidomide in newly diagnosed elderly myeloma patients: an individual patient data meta-analysis of six randomized trials

    Palumbo, A., Waage, A., Hulin, C., Beksac, M., Zweegman, S., Gay, F., Gimsing, P., Leleu, X., Wijermans, P., Sucak, G., Pezzatti, S., Juliusson, G., Pégourié, B., Schaafsma, M., Galli, M., Turesson, I., Kolb, B., van der Holt, B., Baldi, I., Rolke, J., Ciccone, G., Wetterwald, M., Lokhorst, H., Boccadoro, M., Rodon, P. & Sonneveld, P., 2013, In : Haematologica. 98, 1, p. 87-94

    Research output: Contribution to journalJournal articleResearchpeer-review

  43. 2012
  44. Published

    Den Hæmatologiske Fællesdatabase

    Brown, P. D. N., Nørgaard, J. M., Gimsing, P., Hasselbalch, H., Abildgård, N., Jensen, P. & Bukh, A., 2012, In : Ugeskrift for Laeger. 174, 42, p. 2526

    Research output: Contribution to journalJournal articleResearchpeer-review

  45. Published

    Thalidomide and dexamethasone vs. bortezomib and dexamethasone for melphalan refractory myeloma: a randomized study

    Hjorth, M., Hjertner, Ø., Knudsen, L. M., Gulbrandsen, N., Holmberg, E., Pedersen, P. T., Andersen, N. F., Andréasson, B., Billström, R., Carlson, K., Carlsson, M. S., Flogegård, M., Forsberg, K., Gimsing, P., Karlsson, T., Linder, O., Nahi, H., Othzén, A., Swedin, A. & Nordic Myeloma Study Group (NMSG), 2012, In : European Journal of Haematology. 88, 6, p. 485-96 12 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  46. Published

    Vascular endothelial growth factor (VEGF) gene polymorphisms may influence the efficacy of thalidomide in multiple myeloma

    Andersen, N. F., Vogel, U. B., Klausen, T. W., Gimsing, P., Gregersen, H., Abildgaard, N. & Vangsted, A. J., 2012, In : International Journal of Cancer. 131, p. E636-E642

    Research output: Contribution to journalJournal articleResearchpeer-review

  47. 2011
  48. Published

    Single nucleotide polymorphisms in the promoter region of the IL1B gene influence outcome in multiple myeloma patients treated with high-dose chemotherapy independently of relapse treatment with thalidomide and bortezomib

    Vangsted, A. J., Klausen, T. W., Abildgaard, N., Andersen, N. F., Gimsing, P., Gregersen, H., Nexø, B. A. & Vogel, U., 24 Feb 2011, In : Annals of Hematology. 90, 10, p. 1173-1181

    Research output: Contribution to journalJournal articleResearchpeer-review

  49. Published

    Behandling av myelom när högdoskemoterapi inte är möjlig. Nya läkemedel--alternativ för äldre patienter

    Mellstedt, H., Gimsing, P. & Waage, A., 2011, In : Laekartidningen. 108, 42, p. 2090-4 5 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  50. Published

    Personalized therapy in multiple myeloma according to patient age and vulnerability: a report of the European Myeloma Network (EMN)

    Palumbo, A., Bringhen, S., Ludwig, H., Dimopoulos, M. A., Bladé, J., Mateos, M. V., Rosiñol, L., Boccadoro, M., Cavo, M., Lokhorst, H., Zweegman, S., Terpos, E., Davies, F., Driessen, C., Gimsing, P., Gramatzki, M., Hàjek, R., Johnsen, H. E., Leal Da Costa, F., Sezer, O., Spencer, A., Beksac, M., Morgan, G., Einsele, H., San Miguel, J. F. & Sonneveld, P., 2011, In : Blood. 118, 17, p. 4519-29 11 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  51. Published

    Thalidomide for previously untreated elderly patients with multiple myeloma: meta-analysis of 1685 individual patient data from 6 randomized clinical trials

    Fayers, P. M., Palumbo, A., Hulin, C., Waage, A., Wijermans, P., Beksaç, M., Bringhen, S., Mary, J-Y., Gimsing, P., Termorshuizen, F., Haznedar, R., Caravita, T., Moreau, P., Turesson, I., Musto, P., Benboubker, L., Schaafsma, M., Sonneveld, P., Facon, T. & Nordic Myeloma Study Group, 2011, In : Blood. 118, 5, p. 1239-47 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  52. Published

    The importance of a sub-region on chromosome 19q13.3 for prognosis of multiple myeloma patients after high-dose treatment and stem cell support: a linkage disequilibrium mapping in RAI and CD3EAP

    Vangsted, A. J., Klausen, T. W., Gimsing, P., Abildgaard, N., Andersen, N. F., Gregersen, H., Nexø, B. A. & Vogel, U. B., 2011, In : Annals of Hematology. 90, 6, p. 675-684

    Research output: Contribution to journalJournal articleResearchpeer-review

  53. 2010
  54. Published

    Increased level of both CD4+FOXP3+ regulatory T cells and CD14+HLA-DR⁻/low myeloid-derived suppressor cells and decreased level of dendritic cells in patients with multiple myeloma

    Brimnes, M. K., Vangsted, A. J., Knudsen, L. M., Gimsing, P., Gang, A. O., Johnsen, H. & Svane, I. M., 1 Dec 2010, In : Scandinavian Journal of Immunology. 72, 6, p. 540-7 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  55. Published

    Effect of pamidronate 30 mg versus 90 mg on physical function in patients with newly diagnosed multiple myeloma (Nordic Myeloma Study Group): a double-blind, randomised controlled trial

    Gimsing, P., Carlson, K., Turesson, I., Fayers, P., Waage, A., Vangsted, A., Mylin, A., Gluud, C., Juliusson, G., Gregersen, H., Hjorth-Hansen, H., Nesthus, I., Bahn, I. M. D., Westin, J., Nielsen, J. L., Meldgaard Knudsen, L., Ahlberg, L., Hjorth, M., Abildgaard, N., Andersen, N. F., Linder, O. & Wisløff, F., 1 Oct 2010, In : Lancet Oncology. 11, 10, p. 973-82 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  56. Published

    Melphalan and prednisone plus thalidomide or placebo in elderly patients with multiple myeloma

    Waage, A., Gimsing, P., Fayers, P., Abildgaard, N., Ahlberg, L., Björkstrand, B., Carlson, K., Bahn, I. M. D., Forsberg, K., Gulbrandsen, N., Haukås, E., Hjertner, O., Hjorth, M., Karlsson, T., Meldgaard Knudsen, L., Nielsen, J. L., Linder, O., Mellqvist, U-H., Nesthus, I., Rolke, J., Strandberg, M., Sørbø, J. H., Wisløff, F., Juliusson, G., Turesson, I. & Nordic Myeloma Study Group, 2 Sep 2010, In : Blood. 116, 9, p. 1405-12 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  57. Published

    Improved survival of multiple myeloma patients with late relapse after high-dose treatment and stem cell support, a population-based study of 348 patients in Denmark in 1994-2004

    Vangsted, A. J., Klausen, T. W., Andersen, N. F., Abildgaard, N., Gang, A. O., Gregersen, H., Vogel, U. & Gimsing, P., 1 Sep 2010, In : European Journal of Haematology. 85, 3, p. 209-16 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  58. Published

    Multiparametric flow cytometry profiling of neoplastic plasma cells in multiple myeloma

    Johnsen, H. E., Bøgsted, M., Klausen, T. W., Gimsing, P., Schmitz, A., Kjaersgaard, E., Damgaard, T., Voss, P., Knudsen, L. M., Mylin, A. K., Nielsen, J. L., Björkstrand, B., Gruber, A., Lenhoff, S., Remes, K., Dahl, I. M., Fogd, K., Dybkaer, K. & Nordic Myeloma Study (NMSG), 1 Sep 2010, In : Cytometry. Part B: Clinical Cytometry. 78, 5, p. 338-47 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  59. Published

    No influence of the polymorphisms CYP2C19 and CYP2D6 on the efficacy of cyclophosphamide, thalidomide, and bortezomib in patients with Multiple Myeloma

    Vangsted, A. J., Søeby, K., Klausen, T. W., Abildgaard, N., Andersen, N. F., Gimsing, P., Gregersen, H., Vogel, U., Werge, T. & Rasmussen, H. B., 4 Aug 2010, In : B M C Cancer. 10, p. 404 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  60. Published

    Improved survival for multiple myeloma in denmark based on autologous stem cell transplantation and novel drug therapy in collaborative trials: analysis of accrual, prognostic variables, selection bias, and clinical behavior on survival in more than 1200 patients in trials of the nordic myeloma study group

    Johnsen, H. E., Klausen, T. W., Boegsted, M., Lenhoff, S., Gimsing, P., Christiansen, I., Gedde-Dahl, T., Lindås, R., Mellqvist, U-H. & Nordic Myeloma Study Group, 1 Aug 2010, In : Clinical Lymphoma & Myeloma. 10, 4, p. 290-6 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

Previous 1 2 Next

ID: 32593